These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 100811)

  • 1. The effect of lithium on amphetamine-induced locomotor stimulation.
    Berggren U; Tallstedt L; Ahlenius S; Engel J
    Psychopharmacology (Berl); 1978 Sep; 59(1):41-5. PubMed ID: 100811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression by GABAergic drugs of the locomotor stimulation induced by morphine, amphetamine, and apomorphine: evidence for both pre- and post-synaptic inhibition of catecholamine systems.
    Cott J; Engel J
    J Neural Transm; 1977; 40(4):253-68. PubMed ID: 18553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locomotor hyperactivity induced by MK-801 in rats.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol Pharm; 1991; 43(6):449-58. PubMed ID: 1687944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of lithium on the locomotor stimulation induced by dependence-producing drugs.
    Berggren U; Engel J; Liljequist S
    J Neural Transm; 1981; 50(2-4):157-64. PubMed ID: 6264028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
    Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lithium on behaviour and central monoamines.
    Engel J; Berggren U
    Acta Psychiatr Scand Suppl; 1980; 280():133-43. PubMed ID: 6773300
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of piribedil (ET495) on components of locomotor activity.
    Jenner P; Marsden CD
    Eur J Pharmacol; 1975 Aug; 33(1):211-5. PubMed ID: 1175688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of propranolol on the locomotor stimulation induced by activation of postsynaptic catecholamine receptors.
    Hallberg H; Almgren O; Engel J; Jonason J
    Psychopharmacology (Berl); 1981; 72(3):227-31. PubMed ID: 6261288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interaction of sydnocarb with preparations influencing the metabolism of catecholamines].
    Al'tshuler RA; Roshchina LF; Mashkovskiĭ MD
    Farmakol Toksikol; 1976; 39(1):9-14. PubMed ID: 943326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroconvulsive shock and postsynaptic catecholamine effects: increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS.
    Modigh K
    J Neural Transm; 1975; 36(1):19-32. PubMed ID: 164522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of clonidine on locomotor activity in mice.
    Maj J; Sowińska H; Baran L; Kapturkiewicz Z
    Life Sci I; 1972 May; 11(10):483-91. PubMed ID: 4676386
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice.
    Jenkins OF; Jackson DM
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):7-11. PubMed ID: 3877878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of lithium on presynaptic sites of catecholaminergic neurons in the mouse.
    Ushijima I; Yamada K; Furukawa T
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):58-67. PubMed ID: 3094470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of ethanol's central stimulation in mice by small doses of catecholamine-receptor agonists.
    Strömbom U; Svensson TH; Carlsson A
    Psychopharmacology (Berl); 1977 Mar; 51(3):293-9. PubMed ID: 403547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between (+)- and (-)-amphetamine in effects on locomotor activity and L-dopa potentiating action in mice.
    Strömberg U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(2):171-9. PubMed ID: 1143358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of apomorphine and clonidine on locomotor activity in mice after long term treatment with haloperidol.
    Dunstan R; Jackson DM
    Clin Exp Pharmacol Physiol; 1977; 4(2):131-41. PubMed ID: 195762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.
    Svensson K; Johansson AM; Magnusson T; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):234-45. PubMed ID: 2880302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.